Optimal dose of adrenaline auto-injector for children and young people at risk of anaphylaxis: A phase IV randomized controlled crossover study.

Patel, Nandinee; Isaacs, Emily; Duca, Bettina; Nagaratnam, Nanthagopan; Donovan, Jackie; Fontanella, Sara; Turner, Paul J

Patel, Nandinee; Isaacs, Emily; Duca, Bettina; Nagaratnam, Nanthagopan; Donovan, Jackie; Fontanella, Sara; Turner, Paul J.

Afiliação

Patel N; National Heart & Lung Institute, Imperial College London, London, UK.
Isaacs E; National Heart & Lung Institute, Imperial College London, London, UK.
Duca B; National Heart & Lung Institute, Imperial College London, London, UK.
Nagaratnam N; Department of Clinical Biochemistry, Royal Brompton and Harefield NHS Trust, London, UK.
Donovan J; Department of Clinical Biochemistry, Royal Brompton and Harefield NHS Trust, London, UK.
Fontanella S; National Heart & Lung Institute, Imperial College London, London, UK.
Turner PJ; National Heart & Lung Institute, Imperial College London, London, UK.

Allergy ; 78(7): 1997-2006, 2023 07.

Article em En | MEDLINE | ID: mdl-36794963

Assuntos

Anafilaxia; Epinefrina; Adulto; Adolescente; Masculino; Criança; Humanos; Feminino; Epinefrina/uso terapêutico; Anafilaxia/tratamento farmacológico; Estudos Cross-Over; Método Simples-Cego; Autoadministração; Injeções Intramusculares

Palavras-chave

adrenaline; anaphylaxis; auto-injector; epinephrine; stroke volume

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epinefrina / Anafilaxia Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Allergy Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google